Power Law company profile

BostonGene

Health Tech & Medtech · Waltham, United States · Founded 2015 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Investors

3 investors on BostonGene's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

NEC Corporation

Series B+ 2 investors entered at this stage

Impact Investment Capital

Japan Industrial Partners

Global footprint

Where BostonGene has talent and traffic

AI talent share

1.9% of workforce is AI talent
(7 of 368 staff)

Core AI20.54%

Other AI51.36%

Non-AI workforce36198.1%

Web traffic by country

23K monthly visits
across markets

🇺🇸 United States88.7%

🇮🇳 India3.9%

🇬🇧 United Kingdom3.5%

🇩🇪 Germany2.2%

Top 4 markets shown

Patent intelligence

$88M patent portfolio · 52 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$88M

8.8% of valuation · 2.8× the top peer Tempus ($32M)

52 active patent families

Where BostonGene innovates BioinformaticsPathologyExpression dataComputational biologyOncology

Above peer median on Market

Quality vs same-sector peers

BostonGene on the five Patsnap quality dimensions

BostonGene in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where BostonGene concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across BostonGene and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See BostonGene on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo